OCGN: Ocugen Inc
OCGN exchange rate has changed by -6.57% for today. During the day, the instrument was traded at a low of 1.28 and at a high of 1.37.
Follow Ocugen Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
OCGN News
- Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?
- Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care
- Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?
- OCGN's Catalyst Calendar for Trial Data and Filings Through 2028
- Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern
- 5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com
- Ocugen (OCGN) Upgraded to Buy: Here's Why
- OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
- Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates
- Earnings This Week – May 4- May 8, 2026 - TipRanks.com
- OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
- OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
- Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
- Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
- OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
- OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
- MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock?
- Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?
- OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
- Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
- Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study
- Ocugen, Inc. (OCGN) Discusses Top Line Results From Phase II ArMaDa Trial of OCU410 in Geographic Atrophy Transcript
- OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development
- Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data
Frequently Asked Questions
What is OCGN stock price today?
Ocugen Inc stock is priced at 1.28 today. It trades within 1.28 - 1.37, yesterday's close was 1.37, and trading volume reached 4003. The live price chart of OCGN shows these updates.
Does Ocugen Inc stock pay dividends?
Ocugen Inc is currently valued at 1.28. Dividend policy depends on the company, while investors also watch 33.33% and USD. View the chart live to track OCGN movements.
How to buy OCGN stock?
You can buy Ocugen Inc shares at the current price of 1.28. Orders are usually placed near 1.28 or 1.58, while 4003 and -6.57% show market activity. Follow OCGN updates on the live chart today.
How to invest into OCGN stock?
Investing in Ocugen Inc involves considering the yearly range 0.90 - 2.72 and current price 1.28. Many compare -7.25% and -5.88% before placing orders at 1.28 or 1.58. Explore the OCGN price chart live with daily changes.
What are Ocugen Inc stock highest prices?
The highest price of Ocugen Inc in the past year was 2.72. Within 0.90 - 2.72, the stock fluctuated notably, and comparing with 1.37 helps spot resistance levels. Track Ocugen Inc performance using the live chart.
What are Ocugen Inc stock lowest prices?
The lowest price of Ocugen Inc (OCGN) over the year was 0.90. Comparing it with the current 1.28 and 0.90 - 2.72 shows potential long-term entry points. Watch OCGN moves on the chart live for more details.
When did OCGN stock split?
Ocugen Inc has gone through stock splits historically. These changes are visible in , 1.37, and 33.33% after corporate actions.
- Previous Close
- 1.37
- Open
- 1.37
- Bid
- 1.28
- Ask
- 1.58
- Low
- 1.28
- High
- 1.37
- Volume
- 4.003 K
- Daily Change
- -6.57%
- Month Change
- -7.25%
- 6 Months Change
- -5.88%
- Year Change
- 33.33%
- Act
- Fcst
- Prev